{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:17:46Z","timestamp":1784593066886,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03275-7","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:51:47Z","timestamp":1774975907000},"page":"832-849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and efficacy of ticagrelor plus aspirin vs. aspirin monotherapy in patients undergoing coronary artery bypass grafting: A meta-analysis with trial sequential analysis"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1025-1068","authenticated-orcid":false,"given":"Bara M.","family":"Hammadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3277-1549","authenticated-orcid":false,"given":"Ayham Mohammad","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3015-3669","authenticated-orcid":false,"given":"Nesreen","family":"Alhamwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez M.","family":"Odat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masooma","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Asawaeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"10388","key":"3275_CR1","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0140-6736(23)00459-2","volume":"401","author":"M Gaudino","year":"2023","unstructured":"Gaudino M, Andreotti F, Kimura T (2023) Current concepts in coronary artery revascularisation. Lancet 401(10388):1611\u20131628. https:\/\/doi.org\/10.1016\/S0140-6736(23)00459-2","journal-title":"Lancet"},{"issue":"10509","key":"3275_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(25)01633-2","volume":"406","author":"S Verma","year":"2025","unstructured":"Verma S et al (2025) Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial. Lancet 406(10509):1223\u20131234. https:\/\/doi.org\/10.1016\/S0140-6736(25)01633-2","journal-title":"Lancet"},{"issue":"3","key":"3275_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41569-019-0249-3","volume":"17","author":"E Caliskan","year":"2020","unstructured":"Caliskan E et al (2020) Saphenous vein grafts in contemporary coronary artery bypass graft surgery. Nat Rev Cardiol 17(3):155\u2013169. https:\/\/doi.org\/10.1038\/s41569-019-0249-3","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"3275_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jama.2022.11966","volume":"328","author":"S Sandner","year":"2022","unstructured":"Sandner S et al (2022) Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery. JAMA 328(6):554. https:\/\/doi.org\/10.1001\/jama.2022.11966","journal-title":"JAMA"},{"issue":"4","key":"3275_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11239-023-02940-5","volume":"57","author":"MS Mauro","year":"2024","unstructured":"Mauro MS et al (2024) Antithrombotic strategies for preventing graft failure in coronary artery bypass graft. J Thromb Thrombolysis 57(4):547\u2013557. https:\/\/doi.org\/10.1007\/s11239-023-02940-5","journal-title":"J Thromb Thrombolysis"},{"key":"3275_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf423","author":"S Sandner","year":"2025","unstructured":"Sandner S et al (2025) Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf423","journal-title":"Eur Heart J"},{"key":"3275_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/HCO.0000000000001078","volume":"38","author":"S Sandner","year":"2023","unstructured":"Sandner S, Redfors B, Gaudino M (2023) Antiplatelet therapy around CABG: the latest evidence. Curr Opin Cardiol 38:484\u2013489. https:\/\/doi.org\/10.1097\/HCO.0000000000001078","journal-title":"Curr Opin Cardiol"},{"issue":"5","key":"3275_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/heartjnl-2023-323097","volume":"110","author":"A Agrawal","year":"2024","unstructured":"Agrawal A et al (2024) Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis. Heart 110(5):323\u2013330. https:\/\/doi.org\/10.1136\/heartjnl-2023-323097","journal-title":"Heart"},{"issue":"11","key":"3275_CR9","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s40262-015-0290-2","volume":"54","author":"R Teng","year":"2015","unstructured":"Teng R (2015) Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update. Clin Pharmacokinet 54(11):1125\u20131138. https:\/\/doi.org\/10.1007\/s40262-015-0290-2","journal-title":"Clin Pharmacokinet"},{"key":"3275_CR10","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.120.050749","volume":"142","author":"LM Willemsen","year":"2020","unstructured":"Willemsen LM et al (2020) Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG). Circulation 142:1799\u20131807. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050749","journal-title":"Circulation"},{"key":"3275_CR11","doi-asserted-by":"publisher","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71\u2013n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"2","key":"3275_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","volume":"38","author":"JH Schiavo","year":"2019","unstructured":"Schiavo JH (2019) An International Register of Systematic Review Protocols. Med Ref Serv Q 38(2):171\u2013180. https:\/\/doi.org\/10.1080\/02763869.2019.1588072","journal-title":"Med Ref Serv Q"},{"key":"3275_CR13","doi-asserted-by":"publisher","unstructured":"Sterne JAC et al (2019) RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 4898l4898\u2013l. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"3275_CR14","doi-asserted-by":"publisher","unstructured":"Sterne JAC et al (2016) ROBINS-I: Aa tool for assessing risk of bias in non-randomised studies of interventions. BMJ 4919i4919\u2013i. https:\/\/doi.org\/10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"issue":"7","key":"3275_CR15","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1177\/21925682221110527","volume":"12","author":"JR Dettori","year":"2022","unstructured":"Dettori JR, Norvell DC, Chapman JR (2022) Fixed-Effect vs Random-Effects Models for Meta-Analysis: 3 Points to Consider. Global Spine J 12(7):1624\u20131626. https:\/\/doi.org\/10.1177\/21925682221110527","journal-title":"Global Spine J"},{"issue":"6965","key":"3275_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/bmj.309.6965.1351","volume":"309","author":"SG Thompson","year":"1994","unstructured":"Thompson SG (1994) Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated. BMJ 309(6965):1351\u20131355. https:\/\/doi.org\/10.1136\/bmj.309.6965.1351","journal-title":"BMJ"},{"key":"3275_CR17","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C (2017) User Manual for Trial Sequential Analysis (TSA), pp 1\u2013119. https:\/\/ctu.dk\/wp-content\/uploads\/2021\/03\/2017-10-10-TSA-Manual-ENG_ER.pdf"},{"key":"3275_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2508026","author":"A Jeppsson","year":"2025","unstructured":"Jeppsson A et al (2025) Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2508026","journal-title":"N Engl J Med"},{"issue":"8","key":"3275_CR19","doi-asserted-by":"publisher","first-page":"e2122597","DOI":"10.1001\/jamanetworkopen.2021.22597","volume":"4","author":"E Bj\u00f6rklund","year":"2021","unstructured":"Bj\u00f6rklund E et al (2021) Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome. JAMA Netw Open 4(8):e2122597\u2013e2122597. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.22597","journal-title":"JAMA Netw Open"},{"issue":"16","key":"3275_CR20","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/jama.2018.3197","volume":"319","author":"Q Zhao","year":"2018","unstructured":"Zhao Q et al (2018) Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting. JAMA 319(16):1677. https:\/\/doi.org\/10.1001\/jama.2018.3197","journal-title":"JAMA"},{"issue":"10","key":"3275_CR21","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1111\/jgh.15030","volume":"35","author":"C Tang","year":"2020","unstructured":"Tang C et al (2020) Upper gastrointestinal mucosal injury associated with ticagrelor plus aspirin, ticagrelor alone, or aspirin alone at 1-year after coronary artery bypass grafting. J Gastroenterol Hepatol 35(10):1720\u20131730. https:\/\/doi.org\/10.1111\/jgh.15030","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"3275_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jamacardio.2016.3028","volume":"1","author":"R Gherli","year":"2016","unstructured":"Gherli R et al (2016) Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting. JAMA Cardiol 1(8):921. https:\/\/doi.org\/10.1001\/jamacardio.2016.3028","journal-title":"JAMA Cardiol"},{"issue":"10","key":"3275_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/heartjnl-2015-308691","volume":"102","author":"J Saw","year":"2016","unstructured":"Saw J et al (2016) Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery. Heart 102(10):763\u2013769. https:\/\/doi.org\/10.1136\/heartjnl-2015-308691","journal-title":"Heart"},{"issue":"6","key":"3275_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.carrev.2019.10.022","volume":"21","author":"K Hesterberg","year":"2020","unstructured":"Hesterberg K et al (2020) A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery. Cardiovasc Revascularization Med 21(6):792\u2013796. https:\/\/doi.org\/10.1016\/j.carrev.2019.10.022","journal-title":"Cardiovasc Revascularization Med"},{"key":"3275_CR25","doi-asserted-by":"publisher","first-page":"e075707","DOI":"10.1136\/bmj-2023-075707","volume":"385","author":"Y Zhu","year":"2024","unstructured":"Zhu Y et al (2024) Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial. BMJ 385:e075707\u2013e075707. https:\/\/doi.org\/10.1136\/bmj-2023-075707","journal-title":"BMJ"},{"issue":"10","key":"3275_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","volume":"131","author":"A Kulik","year":"2015","unstructured":"Kulik A et al (2015) Secondary Prevention After Coronary Artery Bypass Graft Surgery. Circulation 131(10):927\u2013964. https:\/\/doi.org\/10.1161\/CIR.0000000000000182","journal-title":"Circulation"},{"issue":"11","key":"3275_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L et al (2009) Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med 361(11):1045\u20131057. https:\/\/doi.org\/10.1056\/NEJMoa0904327","journal-title":"N Engl J Med"},{"issue":"3","key":"3275_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamainternmed.2019.6447","volume":"180","author":"RD Turgeon","year":"2020","unstructured":"Turgeon RD et al (2020) Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA Intern Med 180(3):420. https:\/\/doi.org\/10.1001\/jamainternmed.2019.6447","journal-title":"JAMA Intern Med"},{"key":"3275_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezz260","author":"M von Scheidt","year":"2019","unstructured":"von Scheidt M et al (2019) Ticagrelor-based antiplatelet regimens in patients treated with coronary artery bypass grafting: a meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg. https:\/\/doi.org\/10.1093\/ejcts\/ezz260","journal-title":"Eur J Cardiothorac Surg"},{"key":"3275_CR30","doi-asserted-by":"publisher","unstructured":"Lawton JS et al (2022) 2021 ACC\/AHA\/SCAI Guideline for Coronary artery revascularization: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation 145(3). https:\/\/doi.org\/10.1161\/CIR.0000000000001038","DOI":"10.1161\/CIR.0000000000001038"},{"issue":"12","key":"3275_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.116.024637","volume":"134","author":"MP Bonaca","year":"2016","unstructured":"Bonaca MP et al (2016) Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction. Circulation 134(12):861\u2013871. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024637","journal-title":"Circulation"},{"issue":"10","key":"3275_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/heartjnl-2015-307858","volume":"102","author":"WAE Parker","year":"2016","unstructured":"Parker WAE, Storey RF (2016) Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54. Heart 102(10):783\u2013789. https:\/\/doi.org\/10.1136\/heartjnl-2015-307858","journal-title":"Heart"},{"issue":"8","key":"3275_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1080\/09537104.2022.2052036","volume":"33","author":"M He","year":"2022","unstructured":"He M et al (2022) Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study). Platelets 33(8):1146\u20131152. https:\/\/doi.org\/10.1080\/09537104.2022.2052036","journal-title":"Platelets"},{"key":"3275_CR34","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","volume":"56","author":"RF Storey","year":"2010","unstructured":"Storey RF et al (2010) Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes. J Am Coll Cardiol 56:1456\u20131462. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.100","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3275_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamaneurol.2021.4514","volume":"79","author":"R Lun","year":"2022","unstructured":"Lun R, Dhaliwal S, Zitikyte G, Roy DC, Hutton B, Dowlatshahi D (2022) Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack. JAMA Neurol 79(2):141. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4514","journal-title":"JAMA Neurol"},{"issue":"11","key":"3275_CR36","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1161\/STROKEAHA.121.035555","volume":"52","author":"SC Johnston","year":"2021","unstructured":"Johnston SC et al (2021) Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Stroke 52(11):3482\u20133489. https:\/\/doi.org\/10.1161\/STROKEAHA.121.035555","journal-title":"Stroke"},{"key":"3275_CR37","doi-asserted-by":"publisher","unstructured":"Wang Y et al (2022) Time course for benefit and risk of ticagrelor and aspirin in acute ischemic stroke or transient ischemic attack. Neurology 99(1). https:\/\/doi.org\/10.1212\/WNL.0000000000200355","DOI":"10.1212\/WNL.0000000000200355"},{"key":"3275_CR38","doi-asserted-by":"publisher","unstructured":"Qu J et al (2021) Dual Antiplatelet therapy with clopidogrel and aspirin versus aspirin monotherapy in patients undergoing coronary artery bypass graft surgery. J Am Heart Assoc 10(11). https:\/\/doi.org\/10.1161\/JAHA.120.020413","DOI":"10.1161\/JAHA.120.020413"},{"key":"3275_CR39","doi-asserted-by":"publisher","unstructured":"Solo K et al (2019) Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ 5476l5476\u2013l. https:\/\/doi.org\/10.1136\/bmj.l5476","DOI":"10.1136\/bmj.l5476"},{"issue":"29","key":"3275_CR40","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/eurheartj\/ehz185","volume":"40","author":"H Schunkert","year":"2019","unstructured":"Schunkert H et al (2019) Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial. Eur Heart J 40(29):2432\u20132440. https:\/\/doi.org\/10.1093\/eurheartj\/ehz185","journal-title":"Eur Heart J"},{"key":"3275_CR41","doi-asserted-by":"publisher","unstructured":"Watanabe A et al (2025) Ticagrelor paradox: systematic review and network meta-analysis. J Am Heart Assoc 14(17). https:\/\/doi.org\/10.1161\/JAHA.125.041959","DOI":"10.1161\/JAHA.125.041959"},{"issue":"13","key":"3275_CR42","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.3390\/ijms241310844","volume":"24","author":"D Cesarini","year":"2023","unstructured":"Cesarini D et al (2023) Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report. Int J Mol Sci 24(13):10844. https:\/\/doi.org\/10.3390\/ijms241310844","journal-title":"Int J Mol Sci"},{"key":"3275_CR43","doi-asserted-by":"publisher","first-page":"104349","DOI":"10.1016\/j.resp.2024.104349","volume":"331","author":"EA Demir","year":"2025","unstructured":"Demir EA, Gonder O (2025) Ticagrelor-related dyspnea beyond adenosine: Insights into retrotrapezoid hyperactivity. Respir Physiol Neurobiol 331:104349. https:\/\/doi.org\/10.1016\/j.resp.2024.104349","journal-title":"Respir Physiol Neurobiol"},{"issue":"12","key":"3275_CR44","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1160\/TH12-08-0547","volume":"108","author":"M Cattaneo","year":"2012","unstructured":"Cattaneo M, Faioni E (2012) Why does ticagrelor induce dyspnea? Thromb Haemost 108(12):1031\u20131036. https:\/\/doi.org\/10.1160\/TH12-08-0547","journal-title":"Thromb Haemost"},{"key":"3275_CR45","doi-asserted-by":"publisher","unstructured":"Tubek S et al (2023) The effects of P2Y12 adenosine receptors\u2019 inhibitors on central and peripheral chemoreflexes. Front Physiol 14. https:\/\/doi.org\/10.3389\/fphys.2023.1214893","DOI":"10.3389\/fphys.2023.1214893"},{"issue":"6923","key":"3275_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","volume":"308","author":"Collaborative overview of randomised trials of antiplatelet therapy - III","year":"1994","unstructured":"Collaborative overview of randomised trials of antiplatelet therapy - III (1994) Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 308(6923):235\u2013246. https:\/\/doi.org\/10.1136\/bmj.308.6923.235","journal-title":"BMJ"},{"key":"3275_CR47","doi-asserted-by":"publisher","unstructured":"Rao SV et al (2025) 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the management of patients with acute coronary syndromes: A Report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation 151(13). https:\/\/doi.org\/10.1161\/CIR.0000000000001309","DOI":"10.1161\/CIR.0000000000001309"},{"key":"3275_CR48","doi-asserted-by":"publisher","unstructured":"Giacoppo D et al (Jun. 2025) P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials. BMJ 389:e082561. https:\/\/doi.org\/10.1136\/bmj-2024-082561","DOI":"10.1136\/bmj-2024-082561"},{"key":"3275_CR49","doi-asserted-by":"publisher","unstructured":"Valgimigli M et al (Sep. 2025) Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis. Lancet 406(10508):1091\u20131102. https:\/\/doi.org\/10.1016\/S0140-6736(25)01562-4","DOI":"10.1016\/S0140-6736(25)01562-4"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03275-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03275-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03275-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:32:36Z","timestamp":1781339556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03275-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3275"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03275-7","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Owing to the nature of this research design involving synthesis of existing data, it is exempt from review by the institutional review board (IRB). As a result, no ethical approval was required for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have been offered the opportunity to read the manuscript and clearly declare and consent for publication after approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}